Zacks Sell List Highlights Enzon Pharmaceuticals, Mylan Laboratories, EGL, and STMicroelectronics.

CHICAGO -- Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List - Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): Enzon Pharmaceuticals (NASDAQ:ENZN) and Mylan Laboratories, Inc. (NYSE:MYL). Further, Zacks announced #4 Rankings (Sell) on two other widely held stocks: EGL, Inc. (NASDAQ:EAGL) and STMicroelectronics (NYSE:STM). To see the full Zacks #5 Rank List - Stocks to Sell Now visit: http://at.zacks.com/?id=92 E[acute accent]Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List -- Stocks to Sell Now by 155.5% annually (11.88% vs. 4.65% respectively). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid. E[acute accent]Here is a synopsis of why ENZN and MYL have a Zacks Rank of 5 (Strong Sell) and should most likely be sold or avoided for the next 1 to 3 months. Note that a #5 Strong Sell rating is applied to 5% of all the Zacks ranked stocks: E[acute accent]Enzon Pharmaceuticals (NASDAQ:ENZN) surprised analysts with a first-quarter loss of three cents per share; the consensus estimate had called for profits of two cents per share. It was the second miss in three quarters. ENZN said sales declined for its four internally marketed products. Analysts responded to Enzon's report by slashing earnings estimates for the fourth quarter. Analysts now anticipate profits of just two cents per share, versus eight cents per share 30 days ago. E[acute accent]Mylan Laboratories, Inc. (NYSE:MYL) recently reported fiscal fourth-quarter profits of 19 cents per share. Although the earnings were two cents above expectations, gross margins narrowed 600 basis points to 47% because of pricing pressures. Analysts reacted to the report by cutting their estimates for fiscal 2006 to 81 cents per share from 85 cents -- a 4.7% decline. E[acute accent]Here is a synopsis of why EAGL and STM have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks: E[acute accent]EGL, Inc. (NASDAQ:EAGL) reported first-quarter earnings that were nearly 40% below expectations. The company said profits totaled 11 cents per share versus the consensus estimate of 18 cents per share. It was the second consecutive miss. EGL blamed fuel costs as having a negative impact on margins. As a result, analysts have become more pessimistic about the company's prospects for the remainder of the year. The full year consensus estimate has fallen six cents over the past seven days, dropping to $1.25 per share. E[acute accent]STMicroelectronics (NYSE:STM) described first-quarter revenues as being at the lower end of its forecast and said that pricing pressures were evident across several of its markets. Although profits were two cents above expectations, analysts were quick to slash their full-year forecast. Since the company's late-April earnings release, the consensus 2005 estimate has plunged from 56 cents per share to 38 cents per share -- a 32% decline. E[acute accent]Truly taking advantage of the Zacks Rank requires the understanding of how it works. The free special report; "Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions" is available to provide this insightful background. Download a free copy now to prosper in the years to come at http://at.zacks.com/?id=93

E[acute accent]About the Zacks Rank

E[acute accent]For over 17 years, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank stocks have generated an average annual return of +32.8%. During the 2000-2002 bear market, Zacks #1 Rank stocks gained 43.8%, while the S&P 500 tumbled 37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have underperformed the S&P 500 by 155.5% annually (+4.65% vs. +11.88%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively. E[acute accent]Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of Zacks #1 Rank stocks and highlights those stocks poised to outperform the market. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=94 E[acute accent]The Zacks Rank, and all of its recommendations, is created by Zacks & Co., member NASD. Zacks.com displays the Zacks Rank with permission from Zacks & Co. on its web site for individual investors.

E[acute accent]About Zacks

E[acute accent]Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind Zacks is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. The goal is to unlock these pros' profitable insights for individual investors hard-pressed to find this valuable information in one source. A free subscription to "Profit from the Pros" weekly e-mail newsletter provides the best way to use these experts' insights for more profitable investing. Register for a free subscription to the Profit From the Pros newsletter at http://at.zacks.com/?id=95 E[acute accent]Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

E[acute accent](a) The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs, and represents the gross returns before management fees.

E[acute accent]Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.